Case Study: Moderna achieves accelerated discovery and more diverse clinical trials with Looker

Moderna uses the right dose of data to boost discovery

Moderna, a biotech pioneer using mRNA to develop vaccines and therapeutics, faced urgent, highly regulated research needs—exacerbated by the COVID‑19 pandemic—while its teams struggled with siloed, manual data workflows (lots of Excel), inconsistent reports, and limited self‑service access to trusted insights. The company needed a cost‑effective, integratable multicloud solution that would improve data quality, exploration, and cross‑team collaboration.

Moderna built a modern multicloud stack—centralizing data in Amazon Redshift with Etleap ETL, adopting Looker for modeling and self‑service analytics, and using Google NLP for ticket sentiment—deployed quickly by a small team. The result: centralized, auditable dashboards that speed decision‑making, free scientists from manual reporting to focus on research, improve clinical trial diversity and representation, optimize shipping to cut costs, and surface user‑experience issues through sentiment analysis.

Moderna

Dave Johnson

VP of Informatics, Data Science, and AI